Royal Philips released its Q1 FY17 results in which comparable sales growth came in below our estimates but profitability outperformed. The lfl revenue was up 2% (vs AV’s estimate: +3%), on the back of low single-digit growth in the HealthTech portfolio (+3% vs AV’s estimate: +5.5%; accounts for c.71% of Q1 17 revenue). Within the segment, revenue in the Personal Health ‘PH’ division increased by 5.2% (vs AV’s estimate: +7%; accounts for c.30% of Q1 17 revenue) l
12 Jun 2017
Good quarterly results; new product launches to propel growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Good quarterly results; new product launches to propel growth
Koninklijke Philips N.V. (PHIA:WBO) | 0 0 1.5% | Mkt Cap: 29,653m
- Published:
12 Jun 2017 -
Author:
Sumit Sayal -
Pages:
4
Royal Philips released its Q1 FY17 results in which comparable sales growth came in below our estimates but profitability outperformed. The lfl revenue was up 2% (vs AV’s estimate: +3%), on the back of low single-digit growth in the HealthTech portfolio (+3% vs AV’s estimate: +5.5%; accounts for c.71% of Q1 17 revenue). Within the segment, revenue in the Personal Health ‘PH’ division increased by 5.2% (vs AV’s estimate: +7%; accounts for c.30% of Q1 17 revenue) l